NCT06319716 LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes
| NCT ID | NCT06319716 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 540 participants |
| Start Date | 2024-12-29 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 540 participants in total. It began in 2024-12-29 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall goal of this study is to examine the efficacy of the video-based Diabetes Self-Management Education and Support (DSMES) (hereafter VIDEO), or the video-based DSMES+community health worker (CHW) intervention (hereafter VIDEO+CHW), compared with a wait-list control group (hereafter CONTROL) to improve glycemic control among Chinese immigrants with uncontrolled Type 2 diabetes in NYC.
Eligibility Criteria
Inclusion Criteria: * self-identify as Chinese American; * be above 18 years old; * have a diagnosis of Type 2 diabetes (T2D) in the medical record; * have had an appointment with a physician for routine T2D care within the past 12 months; * have a most recent HbA1c of at least 7%; * be willing to receive brief videos regarding T2D management; and * possess a smartphone or, if they do not have one, be willing and able to use a study smartphone. Exclusion Criteria: * unable or unwilling to provide informed consent; * unable to participate meaningfully in the intervention (e.g., uncorrected sight and hearing impairment); * unwilling to accept randomization assignment; * is pregnant, plans to become pregnant in the next 6 months, or becomes pregnant during the study; or * is breastfeeding (e.g., they may have potential dietary restrictions).
Contact & Investigator
Lu Hu, PhD
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT06319716 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06319716 currently recruiting?
Yes, NCT06319716 is actively recruiting participants. Contact the research team at Lu.hu@nyulangone.org for enrollment information.
Where is the NCT06319716 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06319716 clinical trial?
NCT06319716 is sponsored by NYU Langone Health. The principal investigator is Lu Hu, PhD at NYU Langone Health. The trial plans to enroll 540 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.